Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details)

v3.21.1
Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details) - $ / shares
 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Equity [Abstract]    
Number of Shares, Outstanding, Beginning balance 579,584 580,171
Number of Shares, Granted   15,792
Number of Shares, Exercised (15,812) (5,249)
Number of Shares, Forfeited and cancelled (18,932) (8,718)
Number of Shares, Outstanding, Ending balance 544,840 581,996
Number of Shares, Exercisable, Ending balance 490,493 414,720
Weighted Average Exercise Price, Outstanding, Beginning balance $ 11.00 $ 11.05
Weighted Average Exercise Price, Granted   8.87
Weighted Average Exercise Price, Exercised 5.77 4.68
Weighted Average Exercise Price, Forfeited and cancelled 12.45 12.56
Weighted Average Exercise Price, Outstanding, Ending balance 11.10 11.02
Weighted Average Exercise Price, Exercisable, Ending balance $ 10.91 $ 10.65
Weighted Average Remaining Contract Term (years), Outstanding, Beginning balance 7 years 6 months 18 days 8 years 7 months 2 days
Weighted Average Remaining Contract Term (years), Outstanding, Ending balance 6 years 9 months 22 days 7 years 10 months 14 days
Weighted Average Remaining Contract Term (years), Exercisable, Ending balance 6 years 8 months 2 days 7 years 6 months 10 days